Latest study released by Data Bridge Market Research on Global
Dengue Treatment Market research with more than 220 market data tables and figures spread through Pages are easy to understand TOC in “Global Dengue Treatment Market research”, so you can get a variety of ways to maximize your profits. This Dengue Treatment market report has been arranged by effectively using technology, new applications and expertise to manage large and complex market data tables and forecast automatically. In this market research report, a thorough SWOT analysis & investment analysis is provided which forecasts imminent opportunities for the market players. The report endows with precise and exact market research information including sound facts and figures which will drive the business in the right direction.
DBMR recently introduced
Global Rett Syndrome Treatment Market Size, Industry Share, Growth, Industry Trends and Forecast To 2027 study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Global Rett Syndrome Treatment Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry. This report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The growth of the Rett Syndrome Treatment market was mainly driven by the increasing R&D spending across the world, however latest COVID scenario and economic slowdown have changed complete mark
Takeda Pharmaceutical Company Limited
Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn s Disease
Wednesday, February 10, 2021 12:15PM IST (6:45AM GMT)
Takeda Applies for Approval for the Company’s First Allogeneic Stem Cell Therapy in Japan
If Approved, Darvadstrocel Would Offer a Potential Cell-Mediated Closure Option for Adult Patients in Japan Who Do Not Respond to Conventional or Biologic Therapies for Complex Perianal Fistulas in Crohn’s Disease
1,2
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and market darvadstrocel (development code: Cx601) for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease (CD).
Liquid segment of the Antacid Market to Grow at Fastest CAGR during Forecast Period.
The market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027.
The report highlights trends prevailing in the global Antacid market, and the drivers and restraints pertaining to the market growth.
Based on dosage form, the antacid market is segmented into tablet, liquid, and others. In 2019, the microbial tablet segment held the largest share of the market. The liquid segment is expected to grow at the fastest rate during the forecast period. liquid dosage form is preferred by children and ageing population due to its flavored/palatable taste. Also, presence of major market players such as Procter & Gamble, Pfizer, GSK GROUP and others are offering liquid antacids which is likely to propel the growth of the segment.